Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Explore which approach carries less risk for retirement: bonds or index funds. Understand volatility, safety, and long-term impact to guide your plan.
24,864 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
A 34% jump in urea prices amid Iran tensions is sending shockwaves beyond farming. This article breaks down how ferti...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
Two very different players dominate the modern financial scene: Ally Financial builds on auto lending with a growing ...
The GENIUS Act's one-year rulemaking deadline lands on July 18, placing stablecoin issuers under intense regulatory s...
California is backing electric vehicle buyers with a new point-of-sale rebate program. For Rivian, this policy shift ...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...
DTI's 2025 earnings narrative sheds light on demand for drilling tools and oilfield equipment. This guide breaks down...
Feb 2026 marks a turning point for buyers, with discounts piling up across the market. This guide breaks down where s...
Living with bad credit can make debt relief feel out of reach. This guide covers affordable debt relief options for b...